Home › Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success
 

Keywords :   


Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success

2013-09-01 22:41:19| Food - Topix.net

Daiichi Sankyo Co.' s experimental blood thinner edoxaban was found to be as effective and safer than standard treatment warfarin in a study that clears the way for the Japanese company to compete with drugmakers including Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Co.

Tags: study success drug race

Category:Food and Related Products

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Update Statement
05.10Summary for Tropical Storm Milton (AT4/AL142024)
05.10Eastern North Pacific Tropical Weather Outlook
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
More »